Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

FuRST 2.0 Cognitive Pre-Testing
FuRST 2.0: Cognitive Pre-Testing Study for a New Functional Rating Scale for Use in Huntington's Disease
Status: Enrolling
Updated:  8/7/2017
CENTRE FOR MOVEMENT DISORDERS (Neuropharm Consulting)
mi
from
Toronto,
FuRST 2.0 Cognitive Pre-Testing
FuRST 2.0: Cognitive Pre-Testing Study for a New Functional Rating Scale for Use in Huntington's Disease
Status: Enrolling
Updated: 8/7/2017
CENTRE FOR MOVEMENT DISORDERS (Neuropharm Consulting)
mi
from
Toronto,
Click here to add this to my saved trials
PET Imaging in Chronic Traumatic Encephalopathy
PET Imaging in Chronic Traumatic Encephalopathy
Status: Enrolling
Updated:  8/8/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
PET Imaging in Chronic Traumatic Encephalopathy
PET Imaging in Chronic Traumatic Encephalopathy
Status: Enrolling
Updated: 8/8/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Status: Enrolling
Updated:  8/8/2017
Northeast Valley Health Corporation- Canoga Park
mi
from
Canoga Park, CA
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Status: Enrolling
Updated: 8/8/2017
Northeast Valley Health Corporation- Canoga Park
mi
from
Canoga Park, CA
Click here to add this to my saved trials
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Status: Enrolling
Updated:  8/8/2017
Northeast Valley Health Corporation- Pacoima
mi
from
Pacoima, CA
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Status: Enrolling
Updated: 8/8/2017
Northeast Valley Health Corporation- Pacoima
mi
from
Pacoima, CA
Click here to add this to my saved trials
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Status: Enrolling
Updated:  8/8/2017
Northeast Valley Health Corporation- San Fernando
mi
from
San Fernando, CA
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Status: Enrolling
Updated: 8/8/2017
Northeast Valley Health Corporation- San Fernando
mi
from
San Fernando, CA
Click here to add this to my saved trials
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Status: Enrolling
Updated:  8/8/2017
Northeast Valley Health Corporation- Santa Clarita
mi
from
Santa Clarita, CA
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Status: Enrolling
Updated: 8/8/2017
Northeast Valley Health Corporation- Santa Clarita
mi
from
Santa Clarita, CA
Click here to add this to my saved trials
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Status: Enrolling
Updated:  8/8/2017
Northeast Valley Health Corporation- Valencia
mi
from
Valencia, CA
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Status: Enrolling
Updated: 8/8/2017
Northeast Valley Health Corporation- Valencia
mi
from
Valencia, CA
Click here to add this to my saved trials
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Status: Enrolling
Updated:  8/8/2017
Northeast Valley Health Corporation- Van Nuys
mi
from
Van Nuys, CA
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Status: Enrolling
Updated: 8/8/2017
Northeast Valley Health Corporation- Van Nuys
mi
from
Van Nuys, CA
Click here to add this to my saved trials
CPC-201 Alzheimer's Disease Type Dementia: PET Study
Phase II, Modified Single-Blind, Sequential Treatment, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Cerebral Efficacy of CPC-201 in Patients With Alzheimer's Disease Type Dementia: PET Study
Status: Enrolling
Updated:  8/8/2017
Henry Ford Health System--West Bloomfield Hospital
mi
from
West Bloomfield Township, MI
CPC-201 Alzheimer's Disease Type Dementia: PET Study
Phase II, Modified Single-Blind, Sequential Treatment, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Cerebral Efficacy of CPC-201 in Patients With Alzheimer's Disease Type Dementia: PET Study
Status: Enrolling
Updated: 8/8/2017
Henry Ford Health System--West Bloomfield Hospital
mi
from
West Bloomfield Township, MI
Click here to add this to my saved trials
Psychological Treatments for Scleroderma
Psychosocial Interventions for Scleroderma
Status: Enrolling
Updated:  8/8/2017
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Psychological Treatments for Scleroderma
Psychosocial Interventions for Scleroderma
Status: Enrolling
Updated: 8/8/2017
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Multimodal Exercises to Improve Leg Function After Spinal Cord Injury
A Hebbian Approach to Regaining Control of Spared Circuits in Spinal Cord Injury
Status: Enrolling
Updated:  8/11/2017
James J. Peters VA Medical Center, Bronx, NY
mi
from
The Bronx, NY
Multimodal Exercises to Improve Leg Function After Spinal Cord Injury
A Hebbian Approach to Regaining Control of Spared Circuits in Spinal Cord Injury
Status: Enrolling
Updated: 8/11/2017
James J. Peters VA Medical Center, Bronx, NY
mi
from
The Bronx, NY
Click here to add this to my saved trials
Dietary Intake in Adults From the GA2LEN Folow-up Survey
Dietary Intake, Allergy and Respiratory Diseases in European Adults From the GA2LEN Follow-up Survey
Status: Enrolling
Updated:  8/15/2017
Johns Hopkins Bloomberg School of Public Health
mi
from
Baltimore, MD
Dietary Intake in Adults From the GA2LEN Folow-up Survey
Dietary Intake, Allergy and Respiratory Diseases in European Adults From the GA2LEN Follow-up Survey
Status: Enrolling
Updated: 8/15/2017
Johns Hopkins Bloomberg School of Public Health
mi
from
Baltimore, MD
Click here to add this to my saved trials
Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial
A Randomized, Double-Blind, Placebo-Controlled Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial
Status: Enrolling
Updated:  8/16/2017
Clinical Research Facility
mi
from
Chicago, IL
Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial
A Randomized, Double-Blind, Placebo-Controlled Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial
Status: Enrolling
Updated: 8/16/2017
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial
A Randomized, Double-Blind, Placebo-Controlled Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial
Status: Enrolling
Updated:  8/16/2017
Clinical Research Facility
mi
from
Boston, MA
Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial
A Randomized, Double-Blind, Placebo-Controlled Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial
Status: Enrolling
Updated: 8/16/2017
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial
A Randomized, Double-Blind, Placebo-Controlled Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial
Status: Enrolling
Updated:  8/16/2017
Clinical Research Facility
mi
from
New York, NY
Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial
A Randomized, Double-Blind, Placebo-Controlled Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial
Status: Enrolling
Updated: 8/16/2017
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy
A Two-part Placebo-controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy (SBMA)
Status: Enrolling
Updated:  8/17/2017
Novartis Investigational Site
mi
from
Orange, CA
Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy
A Two-part Placebo-controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy (SBMA)
Status: Enrolling
Updated: 8/17/2017
Novartis Investigational Site
mi
from
Orange, CA
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy
A Two-part Placebo-controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy (SBMA)
Status: Enrolling
Updated:  8/17/2017
National Institutes of Health
mi
from
Bethesda, MD
Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy
A Two-part Placebo-controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy (SBMA)
Status: Enrolling
Updated: 8/17/2017
National Institutes of Health
mi
from
Bethesda, MD
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy
A Two-part Placebo-controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy (SBMA)
Status: Enrolling
Updated:  8/17/2017
Novartis Investigative Site
mi
from
Columbus, OH
Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy
A Two-part Placebo-controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy (SBMA)
Status: Enrolling
Updated: 8/17/2017
Novartis Investigative Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy
A Two-part Placebo-controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy (SBMA)
Status: Enrolling
Updated:  8/17/2017
Novartis Investigative Site
mi
from
Copenhagen,
Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy
A Two-part Placebo-controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy (SBMA)
Status: Enrolling
Updated: 8/17/2017
Novartis Investigative Site
mi
from
Copenhagen,
Click here to add this to my saved trials
ImPACT Online Clinical Study
ImPACT Online Clinical Study
Status: Enrolling
Updated:  8/22/2017
ImPACT Applications Inc.
mi
from
Pittsburgh, PA
ImPACT Online Clinical Study
ImPACT Online Clinical Study
Status: Enrolling
Updated: 8/22/2017
ImPACT Applications Inc.
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Patient Targeted Upper Extremity Rehabilitation After Stroke
Patient-Targeted Upper Extremity Rehabilitation After Stroke
Status: Enrolling
Updated:  8/23/2017
Ralph H. Johnson VA Medical Center, Charleston, SC
mi
from
Charleston, SC
Patient Targeted Upper Extremity Rehabilitation After Stroke
Patient-Targeted Upper Extremity Rehabilitation After Stroke
Status: Enrolling
Updated: 8/23/2017
Ralph H. Johnson VA Medical Center, Charleston, SC
mi
from
Charleston, SC
Click here to add this to my saved trials
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
Status: Enrolling
Updated:  8/25/2017
University of Iowa
mi
from
Iowa City, IA
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
Status: Enrolling
Updated: 8/25/2017
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
Status: Enrolling
Updated:  8/25/2017
Johns Hopkins University
mi
from
Baltimore, MD
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
Status: Enrolling
Updated: 8/25/2017
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
Status: Enrolling
Updated:  8/25/2017
University of California-Davis
mi
from
Sacramento, CA
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
Status: Enrolling
Updated: 8/25/2017
University of California-Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
Status: Enrolling
Updated:  8/25/2017
Colorado Neurological Institute
mi
from
Englewood, CO
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
Status: Enrolling
Updated: 8/25/2017
Colorado Neurological Institute
mi
from
Englewood, CO
Click here to add this to my saved trials
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
Status: Enrolling
Updated:  8/25/2017
University of Miami School of Medicine
mi
from
Miami, FL
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
Status: Enrolling
Updated: 8/25/2017
University of Miami School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
Status: Enrolling
Updated:  8/25/2017
Emory University School of Medicine
mi
from
Atlanta, GA
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
Status: Enrolling
Updated: 8/25/2017
Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
Status: Enrolling
Updated:  8/25/2017
Indiana University School of Medicine
mi
from
Indianapolis, IN
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
Status: Enrolling
Updated: 8/25/2017
Indiana University School of Medicine
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
Status: Enrolling
Updated:  8/25/2017
Hereditary Neurological Disease Centre (HNDC)
mi
from
Wichita, KA
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
Status: Enrolling
Updated: 8/25/2017
Hereditary Neurological Disease Centre (HNDC)
mi
from
Wichita, KA
Click here to add this to my saved trials
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
Status: Enrolling
Updated:  8/25/2017
Hennepin County Medical Center
mi
from
Minneapolis, MN
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
Status: Enrolling
Updated: 8/25/2017
Hennepin County Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
Status: Enrolling
Updated:  8/25/2017
Washington University
mi
from
Saint Louis, MO
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
Status: Enrolling
Updated: 8/25/2017
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
Status: Enrolling
Updated:  8/25/2017
Albany Medical College
mi
from
Albany, NY
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
Status: Enrolling
Updated: 8/25/2017
Albany Medical College
mi
from
Albany, NY
Click here to add this to my saved trials
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
Status: Enrolling
Updated:  8/25/2017
University of Rochester
mi
from
Rochester, NY
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
Status: Enrolling
Updated: 8/25/2017
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
Status: Enrolling
Updated:  8/25/2017
Baylor College of Medicine
mi
from
Houston, TX
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
Status: Enrolling
Updated: 8/25/2017
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
IVPCA in the Management of Pain Following Major Intracranial Surgery
The Safety and Efficacy of IVPCA in the Management of Adult Postoperative Craniotomy Pain: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated:  8/28/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
IVPCA in the Management of Pain Following Major Intracranial Surgery
The Safety and Efficacy of IVPCA in the Management of Adult Postoperative Craniotomy Pain: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated: 8/28/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Delayed Cord Clamping in Very Low Birth Weight Infants
Delayed Cord Clamping at 30 vs. 60 Seconds for Very Low Birth Weight Infants: A Randomized Controlled Trial
Status: Enrolling
Updated:  8/28/2017
University of Chicago Medical Center
mi
from
Chicago, IL
Delayed Cord Clamping in Very Low Birth Weight Infants
Delayed Cord Clamping at 30 vs. 60 Seconds for Very Low Birth Weight Infants: A Randomized Controlled Trial
Status: Enrolling
Updated: 8/28/2017
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Should Chronic Stimulant Medications be Continued Preoperatively in Patients With Attention Deficit Hyperactivity Disorder(ADHD)
Status: Enrolling
Updated:  8/28/2017
Nationwide Children's Hospital
mi
from
Columbus, OH
Should Chronic Stimulant Medications be Continued Preoperatively in Patients With Attention Deficit Hyperactivity Disorder(ADHD)
Status: Enrolling
Updated: 8/28/2017
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus
Evaluation of Efficacy and Safety of Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus
Status: Enrolling
Updated:  8/28/2017
MidAtlantic Epilepsy and Sleep Center
mi
from
Bethesda, MD
Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus
Evaluation of Efficacy and Safety of Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus
Status: Enrolling
Updated: 8/28/2017
MidAtlantic Epilepsy and Sleep Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.
"Rational Polytherapy" Using Perampanel Dual Therapy Anticonvulsant Combination Treatments of Adults With Refractory Focal Epilepsy : a Pilot Study.
Status: Enrolling
Updated:  8/28/2017
MidAtlantic Epilepsy and Sleep Center
mi
from
Bethesda, MD
Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.
"Rational Polytherapy" Using Perampanel Dual Therapy Anticonvulsant Combination Treatments of Adults With Refractory Focal Epilepsy : a Pilot Study.
Status: Enrolling
Updated: 8/28/2017
MidAtlantic Epilepsy and Sleep Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Effects of Exercise on Memory in Healthy and Brain-Injured Individuals
Acute Effects of Exercise on Memory in Healthy and Brain-Injured Individuals
Status: Enrolling
Updated:  8/29/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Effects of Exercise on Memory in Healthy and Brain-Injured Individuals
Acute Effects of Exercise on Memory in Healthy and Brain-Injured Individuals
Status: Enrolling
Updated: 8/29/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  8/29/2017
Clinical Research Facility
mi
from
Kansas City, KA
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Clinical Research Facility
mi
from
Kansas City, KA
Click here to add this to my saved trials
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  8/29/2017
Clinical Research Facility
mi
from
Santa Monica, CA
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Clinical Research Facility
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  8/29/2017
Clinical Research Facility
mi
from
Walnut Creek, CA
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Clinical Research Facility
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  8/29/2017
Clinical Research Facility
mi
from
Milford, CT
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Clinical Research Facility
mi
from
Milford, CT
Click here to add this to my saved trials
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  8/29/2017
Clinical Research Facility
mi
from
Waterbury, CT
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Clinical Research Facility
mi
from
Waterbury, CT
Click here to add this to my saved trials
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  8/29/2017
Clinical Research Facility
mi
from
Bradenton, FL
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Clinical Research Facility
mi
from
Bradenton, FL
Click here to add this to my saved trials
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  8/29/2017
Clinical Research Facility
mi
from
Brandon, FL
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Clinical Research Facility
mi
from
Brandon, FL
Click here to add this to my saved trials
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  8/29/2017
Clinical Research Facility
mi
from
Jupiter, FL
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Clinical Research Facility
mi
from
Jupiter, FL
Click here to add this to my saved trials
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  8/29/2017
Clinical Research Facility
mi
from
Miami, FL
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  8/29/2017
Clinical Research Facility
mi
from
Tampa, FL
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials